bioMérieux S.A. (EPA:BIM)
France · Delayed Price · Currency is EUR 73.90
+0.80 (1.09%)
Aug 20, 2026, 4:34 PM CET
bioMérieux Market Cap
bioMérieux has a market cap or net worth of €8.6 billion as of August 20, 2026. Its market cap has decreased by -42.51% in one year.
Market Cap
8.60B
Enterprise Value
8.37B
Revenue
3.99B
Ranking
n/a
PE Ratio
18.74
Stock Price
€73.90
ChartMarket Cap Chart
Since July 7, 2004, bioMérieux's market cap has increased from 1.18B to 8.60B, an increase of 626.87%. That is a compound annual growth rate of 9.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 8.60B | -33.94% |
| Dec 31, 2025 | 13.02B | 6.63% |
| Dec 31, 2024 | 12.21B | 2.78% |
| Dec 29, 2023 | 11.88B | 2.52% |
| Dec 30, 2022 | 11.59B | -21.58% |
| Dec 31, 2021 | 14.78B | 8.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 93.05B |
| EssilorLuxottica Société anonyme | 75.33B |
| Sartorius Stedim Biotech | 17.56B |
| Ipsen | 13.42B |
| Eurofins Scientific SE | 12.09B |
| ABIVAX Société Anonyme | 8.87B |
| Virbac | 2.76B |
| emeis Société anonyme | 2.25B |